Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Dec 2025 for Annexon, Inc., €119k. Read the official filing
Filing timeline
BuySaleJung Choi
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+11.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Jung Choi: trading record in brief
Jung Choi discloses dealings in 2 companies, chiefly Global Blood Therapeutics, Inc. and Annexon, Inc. In total, 12 filings cover trades dated from 17 August 2015 to 1 December 2025.
Purchases make up the whole of the open-market record (2 purchases, €119k). The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants and 7 option exercises. 2025 to date brings 1 purchase and no sales.
On 3 December 2025 came the latest disclosure, an open-market purchase for €119k in Annexon, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jung Choi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
12 of 12 declarations
